Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial.
Saved in:
| Title: | Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial. |
|---|---|
| Authors: | McInnes N; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada., Hall S; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada., Lochnan HA; Department of Medicine, The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada., Harris SB; Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada., Punthakee Z; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada., Sigal RJ; Departments of Medicine, Cardiac Sciences and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Hramiak I; Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada., Azharuddin M; LMC Diabetes and Endocrinology, Burlington, Ontario, Canada., Liutkus JF; JF Liutkus Medicine Professional Corporation, Cambridge, Ontario, Canada., Yale JF; McGill University, Quebec, Canada., Sultan F; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada., Smith A; Department of Medicine, McMaster University, Hamilton, Ontario, Canada., Otto RE; Department of Medicine, McMaster University, Hamilton, Ontario, Canada., Sherifali D; School of Nursing, McMaster University, Hamilton, Ontario, Canada., Liu YY; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada., Gerstein HC; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada. |
| Corporate Authors: | REMIT-iGlarLixi Collaborative Group |
| Source: | Diabetes, obesity & metabolism [Diabetes Obes Metab] 2023 Nov; Vol. 25 (11), pp. 3347-3355. Date of Electronic Publication: 2023 Aug 14. |
| Publication Type: | Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1463-1326 |
|---|---|
| DOI: | 10.1111/dom.15234 |
